These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17344255)

  • 1. Respiratory function during parenteral opioid titration for cancer pain.
    Estfan B; Mahmoud F; Shaheen P; Davis MP; Lasheen W; Rivera N; Legrand SB; Lagman RL; Walsh D; Rybicki L
    Palliat Med; 2007 Mar; 21(2):81-6. PubMed ID: 17344255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?
    Mercadante S; Villari P; Ferrera P; Casuccio A
    Eur J Pain; 2006 Feb; 10(2):153-9. PubMed ID: 16310719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
    Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
    Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid escalation in patients with cancer pain: the effect of age.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Pain Symptom Manage; 2006 Nov; 32(5):413-9. PubMed ID: 17085267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression.
    Jarzyna D; Jungquist CR; Pasero C; Willens JS; Nisbet A; Oakes L; Dempsey SJ; Santangelo D; Polomano RC
    Pain Manag Nurs; 2011 Sep; 12(3):118-145.e10. PubMed ID: 21893302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain.
    De Conno F; Ripamonti C; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; Arcuri E; Bertetto O;
    Palliat Med; 2008 Apr; 22(3):214-21. PubMed ID: 18477715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients.
    Dahan A; Overdyk F; Smith T; Aarts L; Niesters M
    Pain Physician; 2013; 16(2):E85-94. PubMed ID: 23511694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplemental oxygen is not required in trauma patients treated with IV opiates.
    Mildh LH; Piilonen A; Kirvelä OA
    Am J Emerg Med; 2003 Jan; 21(1):35-8. PubMed ID: 12563577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid safety: is your patient at risk for respiratory depression?
    Smith LH
    Clin J Oncol Nurs; 2007 Apr; 11(2):293-6. PubMed ID: 17573279
    [No Abstract]   [Full Text] [Related]  

  • 18. Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.
    Rauck R; Ma T; Kerwin R; Ahdieh H
    Pain Med; 2008 Oct; 9(7):777-85. PubMed ID: 18950436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study.
    Weinstein SM; Messina J; Xie F
    Cancer; 2009 Jun; 115(11):2571-9. PubMed ID: 19373888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.